XML 38 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Tables)
3 Months Ended
Dec. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of assets and liability measured at fair value on a recurring basis
The assets and liability measured at fair value on a recurring basis were as follows: 
(in millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
as of December 31, 2017
 
 
 
 
Assets
 
 
 
 
 
 
 
 
Investment securities, trading
 
 
 
 
 
 
 
 
Sponsored funds
 
$
17.7

 
$

 
$

 
$
17.7

Debt and other equity securities
 
20.0

 
65.1

 
196.8

 
281.9

Investment securities, available-for-sale
 
 
 
 
 
 
 
 
Sponsored funds
 
112.5

 

 

 
112.5

Debt and other equity securities
 
0.9

 
0.6

 
0.3

 
1.8

Life settlement contracts
 

 

 
13.0

 
13.0

Total Assets Measured at Fair Value
 
$
151.1

 
$
65.7

 
$
210.1

 
$
426.9

 
 
 
 
 
 
 
 
 
Liability
 
 
 
 
 
 
 
 
Contingent consideration liability
 
$

 
$

 
$
62.0

 
$
62.0

(in millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
as of September 30, 2017
 
 
 
 
Assets
 
 
 
 
 
 
 
 
Investment securities, trading
 
 
 
 
 
 
 
 
Sponsored funds
 
$
31.1

 
$

 
$

 
$
31.1

Debt and other equity securities
 
18.2

 
78.4

 
186.8

 
283.4

Investment securities, available-for-sale
 
 
 
 
 
 
 
 
Sponsored funds
 
110.8

 

 

 
110.8

Debt and other equity securities
 
1.0

 
0.6

 
0.3

 
1.9

Life settlement contracts
 

 

 
12.8

 
12.8

Total Assets Measured at Fair Value
 
$
161.1

 
$
79.0

 
$
199.9

 
$
440.0

 
 
 
 
 
 
 
 
 
Liability
 
 
 
 
 
 
 
 
Contingent consideration liability
 
$

 
$

 
$
51.0

 
$
51.0

Schedule of changes in Level 3 assets and liability
Changes in the Level 3 assets and liability were as follows: 
 
 
2017
 
2016
(in millions)
 
Investments
 
Contingent
Consideration
Liability
 
Investments
 
Contingent
Consideration
Liability
for the three months ended December 31,
 
 
 
 
Balance at beginning of period
 
$
199.9

 
$
(51.0
)
 
$
205.1

 
$
(98.1
)
Total realized and unrealized gains (losses)
 
 
 
 
 
 
 
 
Included in investment and other income, net
 
1.2

 

 
0.6

 

Included in general, administrative and other expense
 

 
(4.0
)
 

 
12.2

Purchases
 
5.3

 

 
0.5

 

Sales
 

 

 
(2.4
)
 

Settlements
 

 

 
(1.7
)
 
2.2

Foreign exchange revaluation and other
 
3.7

 
(7.0
)
 
(3.4
)
 

Balance at End of Period
 
$
210.1

 
$
(62.0
)
 
$
198.7

 
$
(83.7
)
Change in unrealized gains (losses) included in net income relating to assets and liability held at end of period
 
$
1.2

 
$
(4.0
)
 
$
(0.1
)
 
$
12.2

Schedule of valuation techniques and significant unobservable inputs used in level 3 fair value measurements
Valuation techniques and significant unobservable inputs used in the Level 3 fair value measurements were as follows:
(in millions)
 
 
 
 
 
 
 
 
as of December 31, 2017
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Range (Weighted Average)
Investment securities, trading – debt and other equity securities
 
$
180.3

 
Market pricing
 
Redemption price
 
$73 per $100 of par
Discount rate
 
18.6%
 
16.5

 
Discounted cash flow
 
Discount rate
 
4.3%–6.7% (5.8%)
Risk premium
 
2.0%–4.7% (3.1%)
 
 
 
 
 
 
 
 
 
Life settlement contracts
 
13.0

 
Discounted cash flow
 
Life expectancy
 
19–121 months (61)
Discount rate
 
8.0%–20.0% (13.2%)
 
 
 
 
 
 
 
 
 
Contingent consideration liability
 
62.0

 
Discounted cash flow
 
AUM growth rate
 
2.1%
Discount rate
 
14.8%

(in millions)
 
 
 
 
 
 
 
 
as of September 30, 2017
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Range (Weighted Average)
Investment securities, trading – debt and other equity securities
 
$
175.7

 
Market pricing
 
Redemption price
 
$73 per $100 of par
Discount rate
 
18.6%
 
11.1

 
Discounted cash flow
 
Discount rate
 
4.1%–6.7% (5.7%)
Risk premium
 
2.0%–4.1% (2.9%)
 
 
 
 
 
 
 
 
Life settlement contracts
 
12.8

 
Discounted cash flow
 
Life expectancy
 
20–123 months (62)
Discount rate
 
8.0%–20.0% (13.2%)
 
 
 
 
 
 
 
 
 
Contingent consideration liability
 
51.0

 
Discounted cash flow
 
AUM growth rate
 
1.3%–9.4% (5.3%)
Discount rate
 
14.6%
Schedule of financial instruments not measured at fair value
Financial instruments that were not measured at fair value were as follows:
(in millions)
 
 
 
December 31, 2017
 
September 30, 2017
 
Fair Value
Level
 
Carrying
Value
 
Estimated
Fair Value
 
Carrying
Value
 
Estimated
Fair Value
Financial Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
1
 
$
8,707.5

 
$
8,707.5

 
$
8,523.3

 
$
8,523.3

Other investments
 
 
 
 
 
 
 
 
 
 
Time deposits
 
2
 
10.6

 
10.6

 
13.4

 
13.4

Cost method investments
 
3
 
54.0

 
74.6

 
46.7

 
67.7

 
 
 
 
 
 
 
 
 
 
 
Financial Liability
 
 
 
 
 
 
 
 
 
 
Debt
 
2
 
$
1,044.5

 
$
1,068.7

 
$
1,044.2

 
$
1,073.5